Quarterly report · Q1
4323.TEDINET S100P08U
Period2022-04-01 → 2022-06-30
Filed2022-08-12
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 45
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥5.1bn | 2022-04-01 → 2022-06-30 | Cons. | Net sales |
| Revenue | ¥21.4bn | 2021-04-01 → 2022-03-31 | Cons. | Net sales (5-year summary) |
| Revenue | ¥4.9bn | 2021-04-01 → 2021-06-30 | Cons. | Net sales |
| Operating income | ¥261m | 2022-04-01 → 2022-06-30 | Cons. | Operating income |
| Operating income | ¥342m | 2021-04-01 → 2021-06-30 | Cons. | Operating income |
| Ordinary income | ¥290m | 2022-04-01 → 2022-06-30 | Cons. | Ordinary income |
| Ordinary income | ¥2.1bn | 2021-04-01 → 2022-03-31 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥349m | 2021-04-01 → 2021-06-30 | Cons. | Ordinary income |
| Profit before tax | ¥290m | 2022-04-01 → 2022-06-30 | Cons. | Income before income taxes |
| Profit before tax | ¥349m | 2021-04-01 → 2021-06-30 | Cons. | Income before income taxes |
| Net income (owners) | ¥224m | 2022-04-01 → 2022-06-30 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥1.3bn | 2021-04-01 → 2022-03-31 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥238m | 2021-04-01 → 2021-06-30 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥231m | 2022-04-01 → 2022-06-30 | Cons. | Profit loss |
| Net income | ¥245m | 2021-04-01 → 2021-06-30 | Cons. | Profit loss |
| Total assets | ¥16.4bn | at 2022-06-30 | Cons. | Assets |
| Total assets | ¥15.5bn | at 2022-03-31 | Cons. | Assets |
| Total assets | ¥13.8bn | at 2021-06-30 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥7.2bn | at 2022-06-30 | Cons. | Liabilities |
| Total liabilities | ¥6.3bn | at 2022-03-31 | Cons. | Liabilities |
| Net assets / equity | ¥9.2bn | at 2022-06-30 | Cons. | Net assets |
| Net assets / equity | ¥9.2bn | at 2022-03-31 | Cons. | Net assets |
| Net assets / equity | ¥7.4bn | at 2021-06-30 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥8.3bn | at 2022-06-30 | Cons. | Cash and deposits |
| Cash and deposits | ¥6.5bn | at 2022-03-31 | Cons. | Cash and deposits |
| Cash & equivalents | ¥8.3bn | at 2022-06-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥6.5bn | at 2022-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥6.6bn | at 2021-06-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥4.9bn | at 2021-03-31d | Cons. | Cash and cash equivalents |
| Operating cash flow | ¥2.1bn | 2022-04-01 → 2022-06-30 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥1.2bn | 2021-04-01 → 2022-03-31 | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥1.8bn | 2021-04-01 → 2021-06-30 | Cons. | Net cash provided by used in operating activities |
| Investing cash flow | −¥64m | 2022-04-01 → 2022-06-30 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥81m | 2021-04-01 → 2022-03-31 | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | ¥6m | 2021-04-01 → 2021-06-30 | Cons. | Net cash provided by used in investment activities |
| Financing cash flow | −¥266m | 2022-04-01 → 2022-06-30 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | ¥487m | 2021-04-01 → 2022-03-31 | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥82m | 2021-04-01 → 2021-06-30 | Cons. | Net cash provided by used in financing activities |
| EPS (basic) | ¥36.51 | 2022-04-01 → 2022-06-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥224.65 | 2021-04-01 → 2022-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥43.08 | 2021-04-01 → 2021-06-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (diluted) | ¥42.96 | 2021-04-01 → 2021-06-30 | Cons. | Diluted earnings per share (5-year summary) |
| Equity ratio | 56.0% | at 2022-06-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 58.9% | at 2022-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 53.6% | at 2021-06-30 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 36
| Segment | Item | Period | Value |
|---|---|---|---|
| Reconciling Itemsreconciling | revenue | 2022-04-01 → 2022-06-30 | −¥26m |
| Reconciling Itemsreconciling | revenue intersegment | 2022-04-01 → 2022-06-30 | −¥26m |
| Reconciling Itemsreconciling | segment profit | 2022-04-01 → 2022-06-30 | −¥513m |
| jpcrp040300-q1r_E05236-000Global Businessreportable segment | revenue | 2022-04-01 → 2022-06-30 | ¥688m |
| jpcrp040300-q1r_E05236-000Global Businessreportable segment | revenue external | 2022-04-01 → 2022-06-30 | ¥682m |
| jpcrp040300-q1r_E05236-000Global Businessreportable segment | revenue intersegment | 2022-04-01 → 2022-06-30 | ¥6m |
| jpcrp040300-q1r_E05236-000Global Businessreportable segment | segment profit | 2022-04-01 → 2022-06-30 | ¥119m |
| jpcrp040300-q1r_E05236-000Medical Big Data Businessreportable segment | revenue | 2022-04-01 → 2022-06-30 | ¥319m |
| jpcrp040300-q1r_E05236-000Medical Big Data Businessreportable segment | revenue external | 2022-04-01 → 2022-06-30 | ¥319m |
| jpcrp040300-q1r_E05236-000Medical Big Data Businessreportable segment | segment profit | 2022-04-01 → 2022-06-30 | ¥11m |
| jpcrp040300-q1r_E05236-000Package Businessreportable segment | revenue | 2022-04-01 → 2022-06-30 | ¥865m |
| jpcrp040300-q1r_E05236-000Package Businessreportable segment | revenue external | 2022-04-01 → 2022-06-30 | ¥865m |
| jpcrp040300-q1r_E05236-000Package Businessreportable segment | revenue intersegment | 2022-04-01 → 2022-06-30 | ¥67,000 |
| jpcrp040300-q1r_E05236-000Package Businessreportable segment | segment profit | 2022-04-01 → 2022-06-30 | ¥132m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2022-04-01 → 2022-06-30 | ¥5.1bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2022-04-01 → 2022-06-30 | ¥5.1bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2022-04-01 → 2022-06-30 | ¥26m |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2022-04-01 → 2022-06-30 | ¥774m |
| Reconciling Itemsreconciling | revenue | 2021-04-01 → 2021-06-30 | −¥18m |
| Reconciling Itemsreconciling | revenue intersegment | 2021-04-01 → 2021-06-30 | −¥18m |
| Reconciling Itemsreconciling | segment profit | 2021-04-01 → 2021-06-30 | −¥448m |
| jpcrp040300-q1r_E05236-000Global Businessreportable segment | revenue | 2021-04-01 → 2021-06-30 | ¥448m |
| jpcrp040300-q1r_E05236-000Global Businessreportable segment | revenue external | 2021-04-01 → 2021-06-30 | ¥445m |
| jpcrp040300-q1r_E05236-000Global Businessreportable segment | revenue intersegment | 2021-04-01 → 2021-06-30 | ¥4m |
| jpcrp040300-q1r_E05236-000Global Businessreportable segment | segment profit | 2021-04-01 → 2021-06-30 | ¥6m |
| jpcrp040300-q1r_E05236-000Medical Big Data Businessreportable segment | revenue | 2021-04-01 → 2021-06-30 | ¥359m |
| jpcrp040300-q1r_E05236-000Medical Big Data Businessreportable segment | revenue external | 2021-04-01 → 2021-06-30 | ¥359m |
| jpcrp040300-q1r_E05236-000Medical Big Data Businessreportable segment | segment profit | 2021-04-01 → 2021-06-30 | ¥51m |
| jpcrp040300-q1r_E05236-000Package Businessreportable segment | revenue | 2021-04-01 → 2021-06-30 | ¥993m |
| jpcrp040300-q1r_E05236-000Package Businessreportable segment | revenue external | 2021-04-01 → 2021-06-30 | ¥993m |
| jpcrp040300-q1r_E05236-000Package Businessreportable segment | revenue intersegment | 2021-04-01 → 2021-06-30 | ¥67,000 |
| jpcrp040300-q1r_E05236-000Package Businessreportable segment | segment profit | 2021-04-01 → 2021-06-30 | ¥317m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2021-04-01 → 2021-06-30 | ¥4.9bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2021-04-01 → 2021-06-30 | ¥4.9bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2021-04-01 → 2021-06-30 | ¥18m |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2021-04-01 → 2021-06-30 | ¥790m |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 491
| Item | Context | Value | Unit |
|---|---|---|---|
| Transactions with other segments | Prior1YTDDuration_jpcrp040300-q1r_E05236-000PackageBusinessReportableSegmentMember | 67000 | JPY |
| Transactions with other segments | Prior1YTDDuration_jpcrp040300-q1r_E05236-000MedicalBigDataBusinessReportableSegmentMember | － | JPY |
| Transactions with other segments | Prior1YTDDuration_jpcrp040300-q1r_E05236-000GlobalBusinessReportableSegmentMember | 3900000 | JPY |
| Transactions with other segments | Prior1YTDDuration_TotalOfReportableSegmentsAndOthersMember | 18321000 | JPY |
| Transactions with other segments | Prior1YTDDuration_ReconcilingItemsMember | -18321000 | JPY |
| Transactions with other segments | Prior1YTDDuration | － | JPY |
| Net sales | Prior1YTDDuration_jpcrp040300-q1r_E05236-000DXAndSIBusinessMember | 3118530000 | JPY |
| Net sales | Prior1YTDDuration_jpcrp040300-q1r_E05236-000PackageBusinessReportableSegmentMember | 993179000 | JPY |
| Net sales | Prior1YTDDuration_jpcrp040300-q1r_E05236-000MedicalBigDataBusinessReportableSegmentMember | 358652000 | JPY |
| Net sales | Prior1YTDDuration_jpcrp040300-q1r_E05236-000GlobalBusinessReportableSegmentMember | 448421000 | JPY |
| Net sales | Prior1YTDDuration_TotalOfReportableSegmentsAndOthersMember | 4918783000 | JPY |
| Net sales | Prior1YTDDuration_ReconcilingItemsMember | -18321000 | JPY |
| Net sales | Prior1YTDDuration | 4900462000 | JPY |
| Operating income | Prior1YTDDuration_jpcrp040300-q1r_E05236-000DXAndSIBusinessMember | 415742000 | JPY |
| Operating income | Prior1YTDDuration_jpcrp040300-q1r_E05236-000PackageBusinessReportableSegmentMember | 316514000 | JPY |
| Operating income | Prior1YTDDuration_jpcrp040300-q1r_E05236-000MedicalBigDataBusinessReportableSegmentMember | 51291000 | JPY |
| Operating income | Prior1YTDDuration_jpcrp040300-q1r_E05236-000GlobalBusinessReportableSegmentMember | 6307000 | JPY |
| Operating income | Prior1YTDDuration_TotalOfReportableSegmentsAndOthersMember | 789855000 | JPY |
| Operating income | Prior1YTDDuration_ReconcilingItemsMember | -447719000 | JPY |
| Operating income | Prior1YTDDuration | 342136000 | JPY |
| Revenues from external customers | CurrentYTDDuration_jpcrp040300-q1r_E05236-000DXAndSIBusinessMember | 3253221000 | JPY |
| Revenues from external customers | CurrentYTDDuration_jpcrp040300-q1r_E05236-000PackageBusinessReportableSegmentMember | 864897000 | JPY |
| Revenues from external customers | CurrentYTDDuration_jpcrp040300-q1r_E05236-000MedicalBigDataBusinessReportableSegmentMember | 319470000 | JPY |
| Revenues from external customers | CurrentYTDDuration_jpcrp040300-q1r_E05236-000GlobalBusinessReportableSegmentMember | 681687000 | JPY |
| Revenues from external customers | CurrentYTDDuration_TotalOfReportableSegmentsAndOthersMember | 5119276000 | JPY |
| Revenues from external customers | CurrentYTDDuration_ReconcilingItemsMember | － | JPY |
| Revenues from external customers | CurrentYTDDuration | 5119276000 | JPY |
| Transactions with other segments | CurrentYTDDuration_jpcrp040300-q1r_E05236-000DXAndSIBusinessMember | 19620000 | JPY |
| Transactions with other segments | CurrentYTDDuration_jpcrp040300-q1r_E05236-000PackageBusinessReportableSegmentMember | 67000 | JPY |
| Transactions with other segments | CurrentYTDDuration_jpcrp040300-q1r_E05236-000MedicalBigDataBusinessReportableSegmentMember | － | JPY |
| Transactions with other segments | CurrentYTDDuration_jpcrp040300-q1r_E05236-000GlobalBusinessReportableSegmentMember | 6173000 | JPY |
| Transactions with other segments | CurrentYTDDuration_TotalOfReportableSegmentsAndOthersMember | 25860000 | JPY |
| Transactions with other segments | CurrentYTDDuration_ReconcilingItemsMember | -25860000 | JPY |
| Transactions with other segments | CurrentYTDDuration | － | JPY |
| Net sales | CurrentYTDDuration_jpcrp040300-q1r_E05236-000DXAndSIBusinessMember | 3272842000 | JPY |
| Net sales | CurrentYTDDuration_jpcrp040300-q1r_E05236-000PackageBusinessReportableSegmentMember | 864965000 | JPY |
| Net sales | CurrentYTDDuration_jpcrp040300-q1r_E05236-000MedicalBigDataBusinessReportableSegmentMember | 319470000 | JPY |
| Net sales | CurrentYTDDuration_jpcrp040300-q1r_E05236-000GlobalBusinessReportableSegmentMember | 687860000 | JPY |
| Net sales | CurrentYTDDuration_TotalOfReportableSegmentsAndOthersMember | 5145137000 | JPY |
| Net sales | CurrentYTDDuration_ReconcilingItemsMember | -25860000 | JPY |
| Net sales | CurrentYTDDuration | 5119276000 | JPY |
| Operating income | CurrentYTDDuration_jpcrp040300-q1r_E05236-000DXAndSIBusinessMember | 512139000 | JPY |
| Operating income | CurrentYTDDuration_jpcrp040300-q1r_E05236-000PackageBusinessReportableSegmentMember | 132186000 | JPY |
| Operating income | CurrentYTDDuration_jpcrp040300-q1r_E05236-000MedicalBigDataBusinessReportableSegmentMember | 10519000 | JPY |
| Operating income | CurrentYTDDuration_jpcrp040300-q1r_E05236-000GlobalBusinessReportableSegmentMember | 119125000 | JPY |
| Operating income | CurrentYTDDuration_TotalOfReportableSegmentsAndOthersMember | 773971000 | JPY |
| Operating income | CurrentYTDDuration_ReconcilingItemsMember | -512590000 | JPY |
| Operating income | CurrentYTDDuration | 261380000 | JPY |
| Document title cover page | FilingDateInstant | Original text (Japanese)四半期報告書 | |
| Clause of stipulation cover page | FilingDateInstant | Original text (Japanese)金融商品取引法第24条の４の７第１項 |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 14 of 14 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass rounding |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |